Single Source for Continuation of the Integrated Islet Distribution Program U24 (Clinical Trial Not Allowed)
Agency: National Institutes of Health
Assistance Listings: 93.847 -- Diabetes, Digestive, and Kidney Diseases Extramural Research
Last Updated: May 20, 2026
Description
This is a NOFO for a Single Source competition that will invite application(s) from eligible organization(s) to apply. Please see Eligibility Section for additional information. In accordance with NIH standard peer-review processes, the application(s) will be peer-reviewed, and only meritorious application(s) will be considered for funding.The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is announcing its intent to issue a single source cooperative agreement award to Beckman Research Institute/City of Hope for the currently funded Integrated Islet Distribution Program...
(IIDP) to renew the program and maintain support for its continuing mission to provide the scientific community with important islet resources for diabetes research. The IIDP facilitates the distribution of human islets to biomedical researchers by establishing partnerships with qualified islet isolation facilities to prepare and distribute human islets. Human islets remain an essential resource for diabetes research to advance our understanding of human islet cell biology, and to promote the development of new therapies for the prevention and treatment of diabetes.This NOFO is associated with the Special Diabetes Program (https://www.niddk.nih.gov/about-niddk/research-areas/diabetes/type-1-diabetes-special-statutory-funding-program/about-special-diabetes-program) which funds research on the prevention, treatment, and cure of type 1 diabetes and its complications, including unique, innovative, and collaborative research consortia and clinical trials networks.
Eligibility
Eligible applicants
Miscellaneous
- Other
Additional information
Only the PI/PDs associated with the award issued under RFA-DK-20-509 to Beckman Research Institute/City of Hope is eligible to apply for this single source funding. Refer to Section III. Eligibility Information in the NOFO for additional information on eligibility.Foreign Organizations/Foreign Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organizations) are not eligible to apply.Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.
Grantor contact information
Description
Division of Diabetes, Endocrinology and Metabolic Diseases
NIDDK_DEM@nih.gov
NIDDK_DEM@nih.gov
Documents
| File name | Description | Last updated |
|---|---|---|
| RFA-DK-27-147-Full-Announcement.html | RFA-DK-27-147-Full-Announcement.html | May 20, 2026 03:50 PM UTC |
Link to additional information
--
Closing: September 30, 2026
Award
$3,300,000
Program Funding
1
Expected awards
$--
Award Minimum
$2,200,000
Award Maximum
Funding opportunity number:
RFA-DK-27-147
Cost sharing or matching requirement:
No
Funding instrument type:
Cooperative agreement
Opportunity Category:
Discretionary
Opportunity Category Explanation:
--
Category of Funding Activity:
Health
Category Explanation:
--
History
Version:
1
Posted date:
May 20, 2026
Archive date:
November 29, 2026
